Precision Health Media, a NYC-based company that delivers specific health condition audiences to pharma and consumer brands, has raised an additional $1m in venture capital.
Backers include Cava Capital, the Conyers Group, Metamorphic Ventures, Geoff Judge, David Arcara, Jamie Driver, and Richard Forman of Health Venture Group.
The company intends to use the funding to expand its sales team and further technology development.
Led by CEO Bill Jennings, Precision Health Media has developed its ConditionMatchTM technology, which uses semantic analysis to identify the most effective contextual pages for “diagnosed audiences” from hundreds of top health sites, and then optimizes ad campaigns continuously for best performance.
The company also named Matthew Fink from Johnson & Johnson as Vice President-Marketing.